TCG Crossover Management »

Pepgen shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5M 1.2M 4.62

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Pepgen

RA Capital Management
Viking Global Investors
Commodore Capital
Vivo Capital
Point72 Asset Management
BVF
Laurion Capital Management
Vanguard Group
Henderson Group
Rtw Investments
Adage Capital Partners GP
Balyasny Asset Management
Woodline Partners
Deep Track Capital
TCG Crossover Management

View all funds holding Pepgen